RSSDepartments

CNS Summit 2022 Abstracts of Poster Presentations

CNS Summit 2022 Abstracts of Poster Presentations

| November 1, 2022

A message from the editor Dear Colleagues: Welcome to the annual CNS Summit Abstracts of Poster Presentations supplement to Innovations in Clinical Neuroscience. We are pleased to provide you with this reference guide to some of the innovative research presented during the CNS Summit 2022 event. The supplement is also available online by visiting www.innovationscns.com. […]

Continue Reading

Letter to the Editor: Steroid Management in a Patient with Myasthenia Gravis Undergoing COVID-19 Vaccination

Letter to the Editor: Steroid Management in a Patient with Myasthenia Gravis Undergoing COVID-19 Vaccination

| July 1, 2022

Funding/financial disclosures. The authors have no conflict of interest relevant to the content of this letter. No funding was received for the preparation of this letter. Innov Clin Neurosci. 2022;19(7–9):8.   Dear Editor: We report the case of a 70-year-old patient affected by ocular myasthenia gravis (MG), diagnosed three years ago due to double vision […]

Continue Reading

Post-stroke Sexual Dysfunction in Men: Epidemiology, Diagnostic Work-up, and Treatment

Post-stroke Sexual Dysfunction in Men: Epidemiology, Diagnostic Work-up, and Treatment

| July 1, 2022

by Rocco Salvatore Calabrò, MD, PhD  Dr. Calabrò is with IRCCS Centro Neurolesi “Bonino-Pulejo” in Messina, Italy. Funding: No funding was provided for this article. Disclosures: The author has no conflicts of interest relevant to the content of this article. Innov Clin Neurosci. 2022;19(7–9):12–16. Abstract Stroke is a leading cause of death and disability throughout […]

Continue Reading

Pre-, Peri-, and Neonatal Factors Associated with Autism Spectrum Disorder: Results of a Lebanese Case-control Study

Pre-, Peri-, and Neonatal Factors Associated with Autism Spectrum Disorder: Results of a Lebanese Case-control Study

| July 1, 2022

by Aline Hajj, PharmD, PhD; Souheil Hallit, PharmD, MSc, MPH, PhD; Rouba El-Khatib, PharmD; Sandra Abi Haidar, PharmD; Fabienne Hajj Moussa Lteif, MSc; Layal Hajj, MSc; Maguy Moudawar, MSc; and Lydia Rabbaa Khabbaz, PharmD, PhD Drs. A. Hajj, El-Khatib, Abi Haidar, and Rabbaa Khabbaz are with the Faculty of Pharmacy, Saint-Joseph University in Beirut, Lebanon. […]

Continue Reading

Psychotherapy for Violent Behavior in Children and Adolescents

Psychotherapy for Violent Behavior in Children and Adolescents

| July 1, 2022

by Kari Harper, MD, and Julie P. Gentile, MD, MBA Dr. Harper is Assistant Professor and Assistant Training Director of Child/Adolescent Fellowship at Wright State University in Dayton, Ohio. Dr. Gentile is Professor and Chair of the Department of Psychiatry at Wright State University in Dayton, Ohio. Funding: No funding was provided for this study. […]

Continue Reading

Quantitative Characterization of the Smoothness of Extended-release Methylphenidate Pharmacokinetic Profiles

Quantitative Characterization of the Smoothness of Extended-release Methylphenidate Pharmacokinetic Profiles

| July 1, 2022

by Michelle D. Po, PhD; Roberto Gomeni, PhD, HDR, FCP; and Bev Incledon, PhD Dr. Po is with Highland Therapeutics Inc. in Toronto, Ontario, Canada. Dr. Gomeni is with PharmacoMetrica France in La Fouillade, France and is an Adjunct Professor with the Division of Pharmacotherapy and Experimental Therapeutics in the UNC Eshelman School of Pharmacy at […]

Continue Reading

A Cannabinoid Hypothesis of Schizophrenia: Pathways to Psychosis

A Cannabinoid Hypothesis of Schizophrenia: Pathways to Psychosis

| July 1, 2022

by Rachel Little, MA, and Dale D’Mello, MD Ms. Little is a science writer in Lansing, Michigan. Dr. D’Mello is Associate Professor Emeritus with the Department of Psychiatry at Michigan State University in East Lansing, Michigan. Funding: No funding was provided for this article. Disclosures: The authors have no conflicts of interest relevant to the […]

Continue Reading

Self-administration of Psilocybin in the Setting of Treatment-resistant Depression

Self-administration of Psilocybin in the Setting of Treatment-resistant Depression

| July 1, 2022

by Ashley Lyons, MPA, PA-C Dr. Lyons is a Doctor of Medical Science in Psychiatry at Rocky Mountain University School of Health Professions in Norfolk, Virginia.  Funding: No funding was provided for this article. Disclosures: The authors have no conflicts of interest relevant to the content of this article. Innov Clin Neurosci. 2022;19(7–9):44–47. Abstract Background: […]

Continue Reading